REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,083,104 | -9.7% | 65,801 | +9.7% | 0.00% | 0.0% |
| Q2 2023 | $1,198,886 | +36.9% | 59,977 | +29.5% | 0.00% | +100.0% |
| Q1 2023 | $875,516 | +12.6% | 46,299 | +35.0% | 0.00% | 0.0% |
| Q4 2022 | $777,804 | +5.8% | 34,295 | +23.4% | 0.00% | 0.0% |
| Q3 2022 | $735,000 | +17.8% | 27,798 | +10.0% | 0.00% | 0.0% |
| Q2 2022 | $624,000 | -8.4% | 25,260 | +23.2% | 0.00% | 0.0% |
| Q1 2022 | $681,000 | +39.8% | 20,509 | +37.8% | 0.00% | 0.0% |
| Q4 2021 | $487,000 | +6.6% | 14,883 | +36.4% | 0.00% | 0.0% |
| Q3 2021 | $457,000 | +88.8% | 10,908 | +74.8% | 0.00% | – |
| Q2 2021 | $242,000 | – | 6,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |